• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Leishmaniasis/Kala Azar
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Leishmaniasis/Kala Azar
    • View Item
    Jan 16, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Guthmann Peru.pdf
    Size:
    126.0Kb
    Format:
    PDF
    Download
    Authors
    Guthmann, J P
    Arlt, D
    Garcia, L M L
    Rosales, M
    de Jesus Sanchez, J
    Alvarez, E
    Lonlas, S
    Conte, M
    Bertoletti, G
    Fournier, C
    Huari, R
    Torreele, E
    Llanos-Cuentas, A
    Show allShow less
    Affiliation
    Epicentre, Paris, France. jguthmann@epicentre.msf.org
    Issue Date
    2005-09
    
    Metadata
    Show full item record
    Journal
    Tropical Medicine & International Health
    Abstract
    Mucocutaneous leishmaniasis (MCL) is an important health problem in many rural areas of Latin America, but there are few data on the results of programmatic approaches to control the disease. We report the results of a control programme in San Martin de Pangoa District, which reports one of the highest prevalences of MCL in Peru. For 2 years (2001--2002), the technicians at the health post were trained in patient case management, received medical support and were supplied with antimonials. An evaluation after 2 years showed the following main achievements: better diagnosis of patients, who were confirmed by microscopy in 34% (82/240) of the cases in 2001 and 60% of the cases (153/254) in 2002; improved follow-up during treatment: 237 of 263 (90%) patients who initiated an antimonial therapy ended the full treatment course; improved follow-up after treatment: 143 of 237 (60%) patients who ended their full treatment were correctly monitored during the required period of 6 (cutaneous cases) or 12 (mucosal cases) months after the end of treatment. These achievements were largely due to the human and logistical resources made available, the constant availability of medications and the close collaboration between the Ministry of Health, a national research institute and an international non-governmental organization. At the end of this period, the health authorities decided to register a generic brand of sodium stibogluconate, which is now in use. This should allow the treatment of a significant number of additional patients, while saving money to invest in other facets of the case management.
    Publisher
    Wiley-Blackwell
    URI
    http://hdl.handle.net/10144/17265
    DOI
    10.1111/j.1365-3156.2005.01460.x
    PubMed ID
    16135192
    Language
    en
    ISSN
    1360-2276
    ae974a485f413a2113503eed53cd6c53
    10.1111/j.1365-3156.2005.01460.x
    Scopus Count
    Collections
    Leishmaniasis/Kala Azar

    entitlement

    Related articles

    • Patients' associations and the control of leishmaniasis in Peru.
    • Authors: Guthmann JP, Calmet J, Rosales E, Cruz M, Chang J, Dedet JP
    • Issue date: 1997
    • [Research in tropical medicine and primary health care in Peru].
    • Authors: Guerra H, Falconí E, Llanos-Cuentas A, Chang J
    • Issue date: 1993 Sep-Oct
    • Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
    • Authors: Llanos-Cuentas A, Tulliano G, Araujo-Castillo R, Miranda-Verastegui C, Santamaria-Castrellon G, Ramirez L, Lazo M, De Doncker S, Boelaert M, Robays J, Dujardin JC, Arevalo J, Chappuis F
    • Issue date: 2008 Jan 15
    • Mucosal leishmaniasis . Current scenario and prospects for treatment.
    • Authors: Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC
    • Issue date: 2008 Jan
    • Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
    • Authors: Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A
    • Issue date: 2007 Jun 15
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.